Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The rapid emergence of antifungal-resistant human-pathogenic fungi
SR Lockhart, A Chowdhary, JAW Gold - Nature Reviews Microbiology, 2023 - nature.com
During recent decades, the emergence of pathogenic fungi has posed an increasing public
health threat, particularly given the limited number of antifungal drugs available to treat …
health threat, particularly given the limited number of antifungal drugs available to treat …
Aspergillus fumigatus and Aspergillosis in 2019
JP Latgé, G Chamilos - Clinical microbiology reviews, 2019 - journals.asm.org
Aspergillus fumigatus is a saprotrophic fungus; its primary habitat is the soil. In its ecological
niche, the fungus has learned how to adapt and proliferate in hostile environments. This …
niche, the fungus has learned how to adapt and proliferate in hostile environments. This …
Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment
Infections caused by the fungal pathogen Aspergillus fumigatus are increasingly resistant to
first-line azole antifungal drugs. However, despite its clinical importance, little is known …
first-line azole antifungal drugs. However, despite its clinical importance, little is known …
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
Antifungal resistance: current trends and future strategies to combat
NP Wiederhold - Infection and drug resistance, 2017 - Taylor & Francis
Antifungal resistance represents a major clinical challenge to clinicians responsible for
treating invasive fungal infections due to the limited arsenal of systemically available …
treating invasive fungal infections due to the limited arsenal of systemically available …
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
DW Denning, J Cadranel… - European …, 2015 - publications.ersnet.org
Chronic pulmonary aspergillosis (CPA) is an uncommon and problematic pulmonary
disease, complicating many other respiratory disorders, thought to affect∼ 240 000 people …
disease, complicating many other respiratory disorders, thought to affect∼ 240 000 people …
[HTML][HTML] Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Abstract The European Society for Clinical Microbiology and Infectious Diseases, the
European Confederation of Medical Mycology and the European Respiratory Society Joint …
European Confederation of Medical Mycology and the European Respiratory Society Joint …
Azole-resistant Aspergillus fumigatus in the environment: Identifying key reservoirs and hotspots of antifungal resistance
Aspergillus fumigatus is an opportunistic human pathogen that causes aspergillosis, a
spectrum of environmentally acquired respiratory illnesses. It has a cosmopolitan distribution …
spectrum of environmentally acquired respiratory illnesses. It has a cosmopolitan distribution …
Antifungal therapy: new advances in the understanding and treatment of mycosis
L Scorzoni, ACA de Paula e Silva, CM Marcos… - Frontiers in …, 2017 - frontiersin.org
The high rates of morbidity and mortality caused by fungal infections are associated with the
current limited antifungal arsenal and the high toxicity of the compounds. Additionally …
current limited antifungal arsenal and the high toxicity of the compounds. Additionally …
The clinical spectrum of pulmonary aspergillosis
The clinical presentation of Aspergillus lung disease is determined by the interaction
between fungus and host. Invasive aspergillosis develops in severely immunocompromised …
between fungus and host. Invasive aspergillosis develops in severely immunocompromised …